Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation
- 5 November 1993
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 262 (5135), 909-911
- https://doi.org/10.1126/science.7694363
Abstract
Although presentation of antigen to the T cell receptor is necessary for the initiation of an immune response, additional molecules expressed on antigen-presenting cells deliver essential costimulatory signals. T cell activation, in the absence of costimulation, results in T cell anergy. The B7-1 protein is a costimulator molecule that regulates interleukin-2 (IL-2) secretion by signaling through the pathway that uses CD28 and CTLA-4 (hereafter referred to as the CD28 pathway). We have cloned a counter-receptor of CD28 and CTLA-4, termed B7-2. Although only 26 percent identical to B7-1, B7-2 also costimulates IL-2 production and T cell proliferation. Unlike B7-1, B7-2 messenger RNA is constitutively expressed in unstimulated B cells. It is likely that B7-2 provides a critical early costimulatory signal determining if the T cell will contribute to an immune response or become anergic.Keywords
This publication has 16 references indexed in Scilit:
- Identification of an Alternative CTLA-4 Ligand Costimulatory for T Cell ActivationScience, 1993
- B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance.The Journal of Experimental Medicine, 1993
- Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.Proceedings of the National Academy of Sciences, 1993
- Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.The Journal of Experimental Medicine, 1993
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clonesNature, 1992
- Selective induction of B7/BB-1 on interferon-γ stimulated monocytes: A potential mechanism for amplification of T cell activation through the CD28 pathwayCellular Immunology, 1991
- CTLA-4 is a second receptor for the B cell activation antigen B7.The Journal of Experimental Medicine, 1991
- Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation.The Journal of Experimental Medicine, 1991
- A Cell Culture Model for T Lymphocyte Clonal AnergyScience, 1990